Ferritin Quantitative Test

C-peptide Rapid Quantitative Test (Chemiluminescence Immunoassay)

C-peptide Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the C-peptide concentration in human serum and plasma that contains heparin /EDTA and other anticoagulants samples, mainly used for auxiliary diagnosis of diabetes diseases.

Product Detail

Application

C-peptide is a substance produced by the pancreas, along with insulin. Insulin is a hormone that controls the body's glucose (blood sugar) levels. Glucose is the primary source of energy for the body. If the body does not produce the appropriate amount of insulin, it may be an indication of diabetes.

 

C-peptide and insulin are released from the pancreas simultaneously and in approximately equal amounts. As a result, a C-peptide test can provide insights into the body's insulin production levels. This test can be a useful way to measure insulin levels because C-peptide tends to remain in the body for a longer duration compared to insulin.

 

The key advantage of using a C-peptide test is that it can offer a more accurate assessment of the body's insulin production capacity. Insulin itself is cleared from the bloodstream relatively quickly, making it more challenging to measure. In contrast, C-peptide has a longer half-life, providing a more reliable indicator of the pancreas's insulin-producing capabilities.

 

By analyzing C-peptide levels, healthcare providers can gain valuable information about the underlying cause of a patient's diabetes, which can inform the most appropriate treatment approach. This test can be particularly useful in differentiating between type 1 and type 2 diabetes, as well as in monitoring the progression of the disease and the effectiveness of insulin therapy.

 

In summary, the C-peptide test provides a valuable tool for healthcare professionals to assess and manage diabetes by offering insights into the body's insulin production and secretion dynamics.

 

Product Specification

Sample Volume

WB: 20μL; Serum/Plasma: 10μL

Test Time

10 mins

Measuring Range

0.1- 40.00 ng/mL

Pack

20T40T100T

Storage

2~30

 

Features

Smart - Photosensitive and Luminescent Microspheres

Rapid - Whole Blood Sample Type Supported & No Centrifuge Needed

Convenient - Room Temperature Storage & Minimal sample consumption

 

Clinical significance

Assessment of Endogenous Insulin Production

Distinguishing Type 1 and Type 2 Diabetes

Monitoring Islet Cell Transplants

Assessment of Insulinoma

Evaluation of Hypoglycemia

 

Leave A Message

Please provide us with the information below, and we'll contact you as soon as possible.

Related Products
HbA1c Rapid Quantitative Test (Chemiluminescence Immunoassay)
HbA1c Rapid Quantitative Test (Chemiluminescence Immunoassay)
HbA1c Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Glycated hemoglobin A1c (HbA1c) concentration in human whole blood that contains EDTA or without anticoagulants samples, mainly used for the supervising of long-term glycemic control in diabetic individuals and auxiliary diagnosis of diabetes and identify patients at risk of diabetes.
INS Rapid Quantitative Test (Chemiluminescence Immunoassay)
INS Rapid Quantitative Test (Chemiluminescence Immunoassay)
INS Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Insulin (INS) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants samples, mainly used for auxiliary diagnosis of diabetes diseases.
Biotime ST2 Rapid Quantitative Test
ST2 Rapid Quantitative Test
ST2 is a member of the interleukin-1 receptor family biomarker and circulating soluble ST2 concentrations are believed to reflect cardiovascular stress and fibrosis. The studies have demonstrated soluble ST2 to be a strong predictor of cardiovascular outcomes in both chronic and acute heart failure. It is a new biomarker that meets all required criteria for a useful biomarker.
Biotime HLC-100 Fully Automated HbA1c Analyzer
HLC-100 Fully Automated HbA1c Analyzer
Biotime’s HLC-100 Fully Automated HbA1c Analyzer provides a prompt, reliable solution for diabetes diagnosis. It utilizes the high performance liquid chromatography (HPLC) analytical technique, a gold standard that helps detect glycosylated hemoglobin (HbA1c) with superior precision. Its capability to measure HbA1c, HbF, and other hemoglobin fragments enables clinicians to make quick, accurate diagnoses, thus facilitating timely treatment for the patient.
Biotime FLI-600 FIA Immunoassay Analyzer
FLI-600 FIA Immunoassay Analyzer
FLI-600 is a fluorescent immunoassay system with 6 channels that uses blood and urine to measure the quantitative concentration of targeted analyte. Its automated test process enables to carry out multiple simultaneous tests for six different samples.
H. Pylori Antigen Qualitative Test(Fluorescence Immunoassay)
H. Pylori Antigen Qualitative Test(Fluorescence Immunoassay)
The Biotime Helicobacter pylori (H.pylori) Antigen Rapid Test is intended to qualitatively detect the Helicobacter pylori (H.pylori) antigen in human faeces samples on Biotime FIA Analyzer by fluorescent immunoassay. The test is used as an early aid diagnosis and screening of  Helicobacter pylori infection. For in vitro diagnostic use only. For professional use only.
Biotime HLC-100 Fully Automated HbA1c Analyzer
HLC-100 Fully Automated HbA1c Analyzer
Biotime’s HLC-100 Fully Automated HbA1c Analyzer provides a prompt, reliable solution for diabetes diagnosis. It utilizes the high performance liquid chromatography (HPLC) analytical technique, a gold standard that helps detect glycosylated hemoglobin (HbA1c) with superior precision. Its capability to measure HbA1c, HbF, and other hemoglobin fragments enables clinicians to make quick, accurate diagnoses, thus facilitating timely treatment for the patient.
Biotime 3 in 1 (cTnI/CK-MB/Myo) rapid fluorescence immunoassay test
3 in 1 (cTnI/CK-MB/Myo) Rapid Quantitative Test
3 in 1 test kit has a very high specificity and sensitivity for the detection of AMI, making a correct and timely diagnosis for patients with chest pain or clinically suspected AMI, and thus providing validly basis for clinicians with prompt rescue and treatment.
Leave A Message

Leave A Message

    Please provide us with the information below, and we'll contact you as soon as possible.

Home

products

about

contact